α-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons

Molecular Neurobiology

Volumn 53, Issue 3, 2016, Pages 1925-1934

  Ortega, Richard ^a,b   Carmona, Asuncion ^a,b   Roudeau, Stéphane ^a,b   Perrin, Laura ^a,b   Dučić, Tanja ^c   Carboni, Eleonora ^d,e   Bohic, Sylvain ^f,g   Cloetens, Peter ^g   Lingor, Paul ^d,e  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE D ETUDES NUCLÉAIRES DE BORDEAUX GRADIGNAN   (France)

^c ALBA SYNCHROTRON LIGHT SOURCE   (Spain)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e Deutsche Forschungsgemeinschaft   (Germany)

^f INSERM   (France)

^g EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

Author keywords

Iron; Neuroimaging; Parkinson s disease; Synchrotron; Synuclein

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SYNUCLEIN; IRON; SNCA PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; INTRACELLULAR SPACE; IRON DISTRIBUTION; IRON METABOLISM; NANOIMAGING; NEUROIMAGING; NONHUMAN; PARKINSON DISEASE; PC12 CELL LINE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SINGLE CELL ANALYSIS; SUBSTANTIA NIGRA; TISSUE LEVEL; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CELL COUNT; CELL SIZE; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE VECTOR; HUMAN; MESENCEPHALON; METABOLISM; NANOTECHNOLOGY; NERVE CELL; SPECTROMETRY; WISTAR RAT;

ALPHA-SYNUCLEIN; ANIMALS; CELL COUNT; CELL SIZE; GENETIC VECTORS; HUMANS; IRON; MESENCEPHALON; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NANOTECHNOLOGY; NEURONS; PC12 CELLS; RATS; RATS, WISTAR; SPECTROMETRY, X-RAY EMISSION;

EID: 84961161950     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9146-x     Document Type: Article

References (52)

1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J (2011) Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol 26(Suppl 1):S1–S58
2. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045–2047
3. Neystat M, Lynch T, Przedborski S, Kholodilov N, Rzhetskaya M, Burke RE (1999) Alpha-synuclein expression in substantia nigra and cortex in Parkinson’s disease. Mov Disord 14:417–422
4. Devine MJ, Gwinn K, Singleton A, Hardy J (2011) Parkinson’s disease and alpha-synuclein expression. Mov Disord 26:2160–2168
5. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840
6. Miller DW, Hague SM, Clarimon J, Baptista M, Gwinn-Hardy K, Cookson MR, Singleton AB (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology 62:1835–1838
7. Wong BX, Duce JA (2014) The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders. Front Pharmacol 5:81
8. Kozlowski H, Luczkowski M, Remelli M, Valensin D (2012) Copper, zinc and iron in neurodegenerative diseases (Alzheimer’s, Parkinson’s and prion diseases). Coord Chem Rev 256:2129–2141
9. Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B (2000) The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20:6048–6054
10. Kostka M, Högen T, Danzer KM, Levin J, Habeck M, Wirth A, Wagner R, Glabe CG, et al (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283:10992–11003
11. Li WJ, Jiang H, Song N, Xie JX (2010) Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells. Neurosci Bull 26:205–210
12. Hillmer AS, Putcha P, Levin J, Högen T, Hyman BT, Kretzschmar H, McLean PJ, Giese A (2010) Converse modulation of toxic alpha-synuclein oligomers in living cells by N’-benzylidene-benzohydrazide derivates and ferric iron. Biochem Biophys Res Commun 391:461–466
13. Peng Y, Wang C, Xu HH, Liu YN, Zhou F (2010) Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes. J Inorg Biochem 104:365–370
14. He Q, Song N, Xu H, Wang R, Xie J, Jiang H (2011) Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells. J Neural Transm 118:397–406
15. Jinsmaa Y, Sullivan P, Gross D, Cooney A, Sharabi Y, Goldstein DS (2014) Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein. Neurosci Lett 569:27–32
16. Friedlich AL, Tanzi RE, Rogers JT (2007) The 5′-untranslated region of Parkinson’s disease alpha-synuclein messengerRNA contains a predicted iron responsive element. Mol Psychiatry 12:222–223
17. Febbraro F, Giorgi M, Caldarola S, Loreni F, Romero-Ramos M (2012) α-Synuclein expression is modulated at the translational level by iron. Neuroreport 23:576–580
18. Scherzer CR, Grass JA, Liao Z, Pepivani I, Zheng B, Eklund AC, Ney PA, Ng J et al (2008) GATA transcription factors directly regulate the Parkinson’s disease-linked gene alpha-synuclein. Proc Natl Acad Sci U S A 105:10907–10912
19. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson’s disease: an X-ray microanalysis. J Neurochem 56:446–451
20. Castellani RJ, Siedlak SL, Perry G, Smith MA (2000) Sequestration of iron by Lewy bodies in Parkinson’s disease. Acta Neuropathol 100:111–114
21. Golts N, Snyder H, Frasier M, Theisler C, Choi P, Wolozin B (2002) Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. J Biol Chem 277:16116–16123
22. Binolfi A, Rasia RM, Bertoncini CW, Ceolin M, Zweckstetter M, Griesinger C, Jovin TM, Fernandez CO (2006) Interaction of alpha-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement. J Am Chem Soc 128:9893–9901
23. Bharathi Rao KS (2007) Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson’s disease. Biochem Biophys Res Commun 359:115–120
24. Davies P, Moualla D, Brown DR (2011) Alpha-synuclein is a cellular ferrireductase. PLoS ONE 6:e15814
25. Carmona A, Devès G, Ortega R (2008) Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques. Anal Bioanal Chem 390:1585–1594
26. Ortega R, Devès G, Carmona A (2009) Bio-metals imaging and speciation in cells using proton and synchrotron radiation X-ray microspectroscopy. J R Soc Interface 6:S649–S658
27. Carmona A, Cloetens P, Devès G, Bohic S, Ortega R (2008) Nano-imaging of trace metals by synchrotron X-ray fluorescence into dopaminergic single cells and neurite-like processes. J Anal At Spectrom 23:1083–1088
28. Dučić T, Barski E, Salome M, Koch JC, Bähr M, Lingor P (2013) X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons. J Neurochem 124:250–261
29. Zhu M, Li W, Lu C (2012) Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines. PLoS One 7:e36377
30. Rendón WO, Martínez-Alonso E, Tomás M, Martínez-Martínez N, Martínez-Menárguez JA (2013) Golgi fragmentation is Rab and SNARE dependent in cellular models of Parkinson’s disease. Histochem Cell Biol 139:671–684
31. Lee HJ, Shin SY, Choi C, Lee YH, Lee SJ (2002) Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. J Biol Chem 277:5411–5417
32. Parihar MS, Parihar A, Fujita M, Hashimoto M, Ghafourifar P (2009) Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int J Biochem Cell Biol 41:2015–2024
33. McLean PJ, Kawamata H, Hyman BT (2001) Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons. Neuroscience 104:901–912
34. Rasia RM, Bertoncini CW, Marsh D, Hoyer W, Cherny D, Zweckstetter M, Griesinger C, Jovin TM et al (2005) Structural characterization of copper(II) binding to alpha-synuclein: insights into the bioinorganic chemistry of Parkinson’s disease. Proc Natl Acad Sci U S A 102:4294–4299
35. Brown DR (2009) Metal binding to alpha-synuclein peptides and its contribution to toxicity. Biochem Biophys Res Commun 380:377–381
36. Büttner S, Faes L, Reichelt WN, Broeskamp F, Habernig L, Benke S, Kourtis N, Ruli D, et al (2013) The Ca2+/Mn2+ ion-pump PMR1 links elevation of cytosolic Ca(2+) levels to α-synuclein toxicity in Parkinson’s disease models. Cell Death Differ 20:465–477
37. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K et al (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62:218–229
38. Ying Z, Lin F, Gu W, Su Y, Arshad A, Qing H, Deng Y (2011) α-Synuclein increases U251 cells vulnerability to hydrogen peroxide by disrupting calcium homeostasis. J Neural Transm 118:1165–1172
39. Knöferle J, Ramljak S, Koch JC, Tönges L, Asif AR, Michel U, Wouters FS, Heermann S et al (2010) TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABP. Neurobiol Dis 38:395–404
40. Lingor P, Unsicker K, Krieglstein K (2000) GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide. Exp Neurol 163:55–62
41. Saal KA, Koch JC, Tatenhorst L, Szegő EM, Ribas VT, Michel U, Bähr M, Tönges L et al (2015) AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson’s disease in vitro and in vivo. Neurobiol Dis 73:150–162
42. Taschenberger G, Garrido M, Tereshchenko Y, Bähr M, Zweckstetter M, Kügler S (2011) Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Acta Neuropathol 123:671–683
43. Koch JC, Barski E, Lingor P, Bähr M, Michel U (2011) Plasmids containing NRSE/RE1 sites enhance neurite outgrowth of retinal ganglion cells via sequestration of REST independent of NRSE dsRNA expression. FEBS J 278:3472–3483
44. Galvani P, Colleoni M, Origgi M, Santagostino A (1995) Mitochondrial toxicity of iron and the protective role of ferritin on dopaminergic PC12 cell line. Toxicol in Vitro 9:365–368
45. Koch JC, Tönges L, Barski E, Michel U, Bähr M, Lingor P (2014) ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis 5:e1225
46. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675
47. Burgess A, Vigneron S, Brioudes E, Labbé J-C, Lorca T, Castro A (2010) Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance. Proc Natl Acad Sci U S A 107:12564–12569
48. Roudeau S, Carmona A, Perrin L, Ortega R (2014) Correlative organelle fluorescence microscopy and synchrotron X-ray chemical element imaging in single cells. Anal Bioanal Chem 406:6979–6991
49. Campbell JL, Boyd NI, Grassi N, Bonnick P, Maxwell JA (2010) The Guelph PIXE software package IV. Nucl Inst Methods B 268:3356–3363
50. Mayer M (1997) SIMNRA user’s guide. Report IPP 9/113, Max-Planck-Inst. für Plasmaphysik, Garching, Germany. www2.if.usp.br/~lamfi/guia-simnra.pdf
51. Solé VA, Papillon E, Cotte M, Walter P, Susini J (2007) A multiplatform code for the analysis of energy-dispersive X-ray fluorescence spectra. Spectrochim Acta B 62:63–68
52. Fox J (2005) The R commander: a basic statistics graphical user interface to R. J Stat Softw 14:1–42